Adocia confirms its financial calendar for 2019

Verona Pharma Reports Encouraging Top-Line Data from Three-Day Phase 2 Trial Evaluating Nebulized Ensifentrine (RPL554) on Top of Dual Bronchodilator Therapy for COPD Maintenance

Verona Pharma Receives WHO Approval for “ensifentrine” as Recommended INN for RPL554

HPS Home Power Solutions GmbH begins delivery of the first Picea customer systems

Medigene AG: Additional European patent granted for Medigene’s DC vaccine platform

Expedeon AG licenses Lightning-Link® Rapid Biotinylation technology to Cell Guidance Systems in supply agreement

Sterna biologicals prepares for phase IIb clinical program with GATA-3 antagonist drug candidates SB010 in asthma and SB012 in ulcerative colitis

AYOXXA signs research agreement in the field of ophthalmology with one of the leading pharmaceutical companies

Molecular Health licenses its proprietary predictive analytics to DATEN CAPITAL

Biom’up: Achievement of two major development milestones